TCL Archive Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment May 23, 2014
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012